Views
5 years ago

Tratado de Actualización en Psiquiatría - Fascículo 17

  • Text
  • Postraumatico
  • Compulsivo
  • Especifica
  • Social
  • Psychiatry
  • Trastorno
  • Anxiety
  • Pacientes
  • Ansiedad
  • Tratamiento
Trastornos de ansiedad - Parte 2 - Autora: Dra. Andrea Silvana Rosso

Trastornos

Trastornos de ansiedad (Parte 2) // Referencias bibliográficas social behavior: implications for understanding social anxiety. Biol Psychiatry, 2002. 51(1): p. 11-7. 153. Nutt, D.J., C.J. Bell, and A.L. Malizia, Brain mechanisms of social anxiety disorder. J Clin Psychiatry, 1998. 59 Suppl 17: p. 4-11. 154. Pollack, M.H., Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry, 2001. 62 Suppl 12: p. 24-9. 155. Laufer, N., et al., Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia. Psychiatry Res, 2005. 137(1-2): p. 131-6. 156. Kendler, K.S., et al., The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Arch Gen Psychiatry, 1992. 49(4): p. 273-81. 157. Merikangas, K.R., et al., The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry, 2002. 51(1): p. 81-91. 158. Ollendick, T.H. and D.R. Hirshfeld-Becker, The developmental psychopathology of social anxiety disorder. Biol Psychiatry, 2002. 51(1): p. 44-58. 159. Bustamante, G., Aspectos psicológicos del Trastorno de ansiedad social (TAS). Revista Anxia, 2003. Nº8. 160. Clark, D.M. and F. McManus, Information processing in social phobia. Biol Psychiatry, 2002. 51(1): p. 92-100. 161. Coupland, N.J., Social phobia: etiology, neurobiology, and treatment. J Clin Psychiatry, 2001. 62 Suppl 1: p. 25-35. 162. Straube, T., H.J. Mentzel, and W.H. Miltner, Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia. Biol Psychiatry, 2006. 59(2): p. 162-70. 163. Kendler, K.S., L.M. Karkowski, and C.A. Prescott, Fears and phobias: reliability and heritability. Psychol Med, 1999. 29(3): p. 539-53. 164. Kendler, K.S., J. Myers, and C.A. Prescott, The etiology of phobias: an evaluation of the stress-diathesis model. Arch Gen Psychiatry, 2002. 59(3): p. 242-8. 165. Neale, M.C., et al., Genetics of blood-injury fears and phobias: a population-based twin study. Am J Med Genet, 1994. 54(4): p. 326- 34. 166. Freud, S., Las neuropsicosisi de defensa, in Obras completas de Sigmund Freud, Amorrortu, Editor. 1995: Buenos Aires. p. 41-62. 167. Freud, S., Análisis de la fobia de un niño de cinco años, in Obras completas de Sigmund Freud, Amorrortu, Editor. 1988, Amorrurtu: Buenos Aires. p. 1-116. 168. Valls, J.L., Diccionario Freudiano. 1995, Buenos Aires: Yebenes. 169. Evans, D., Diccionario Introductorio de psicoanálisis lacanianano. Primera edición ed, ed. Paidos. Vol. 1. 1997, Buenos Aires. 217. 170. Peskin, L., Fobias, in Los orígenes del sujeto y su lugar en la clínica psicoanalítica Paidos, Editor. 2003: Buenos AIres. 171. Bobes, J., How is recovery from social anxiety disorder defined? J Clin Psychiatry, 1998. 59 Suppl 17: p. 12-9. 172. Blanco, C., et al., Treatment of Obsessive-Compulsive Disorder by U.S. Psychiatrists. J Clin Psychiatry, 2006. 67(6): p. 946- 951. 173. Perugi, G., et al., Putative clinical subtypes of social phobia: a factor-analytical study. Acta Psychiatr Scand, 2001. 104(4): p. 280- 8. 174. APAL, S.d.D.y.C.A.P.d.A.L., GLADP: Guía Latinoamericana de Diagnóstico Psiquiátrico. 2004, America Latina. 175. Marquez, M., Fobia a los animales: hacia una delimitación de subtipos. Revista Anxia 2003. nº 7. 176. Lydiard, R.B., Social anxiety disorder: comorbidity and its implications. J Clin Psychiatry, 2001. 62 Suppl 1: p. 17-23; discussion 24. 177. Bakken, K., A.S. Landheim, and P. Vaglum, Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences. A study of a consecutive sample of alcoholdependent and poly-substance-dependent patients treated in two counties in Norway. Drug Alcohol Depend, 2005. 80(3): p. 321-8. 178. Morris, E.P., S.H. Stewart, and L.S. Ham, The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clin Psychol Rev, 2005. 25(6): p. 734-60. 179. Yonkers, K.A., I.R. Dyck, and M.B. Keller, An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psychiatr Serv, 2001. 52(5): p. 637- 43. 180. Montgomery, S.A., et al., ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder. Eur Neuropsychopharmacol, 2004. 14(5): p. 425-33. 181. Stein, D.J., et al., Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions. Depress Anxiety, 2004. 20(4): p. 175-81. 182. Stein, D.J., E.W. Andersen, and M. Lader, Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions. Eur Neuropsychopharmacol, 2006. 16(1): p. 33-8. 183. Kasper, S., et al., Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study. Br J Psychiatry, 2005. 186: p. 222-6. 184. Davidson, J.R., et al., Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry, 2004. 61(10): p. 1005-13. 185. Blomhoff, S., et al., Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry, 2001. 179: p. 23-30. 186. Liebowitz, M.R., A.J. Gelenberg, and D. Munjack, Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry, 2005. 62(2): p. 190-8. 187. Foa, E.B., et al., Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 2005. 162(1): p. 151-61. 188. Blanco, C., S.X. Antia, and M.R. Liebowitz, Pharmacotherapy of social anxiety disorder. Biol Psychiatry, 2002. 51(1): p. 109-20. 189. Davidson, J.R., Pharmacotherapy of social phobia. Acta Psychiatr Scand Suppl, 2003(417): p. 65-71. 190. Haug, T.T., et al., Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial. Br J Psychiatry, 2003. 182: p. 312-8. 191. Shear, M.K. and D.C. Beidel, Psychotherapy in the overall Sciens Editorial Tratado de Actualización en Psiquiatría 29

CAPÍTULO XVI Trastornos de ansiedad (Parte 2) // Referencias bibliográficas management strategy for social anxiety disorder. J Clin Psychiatry, 1998. 59 Suppl 17: p. 39-46. 192. Hofmann, S.G., et al., Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry, 2006. 63(3): p. 298-304. 193. Wikinski, S. and G. Jufe, El tratamiento farmacológico en psiquiatría. 1º ed. 2004, Buenos Aires: Editorial Médica Panamericana. 194. Murray, C.J. and A.D. Lopez, Evidence-based health policy-- lessons from the Global Burden of Disease Study. Science, 1996. 274(5288): p. 740-3. 195. Goodwin, R., et al., Helpseeking and access to mental health treatment for obsessive-compulsive disorder. Acta Psychiatr Scand, 2002. 106(2): p. 143-9. 196. Nestadt, G., et al., Obsessive-compulsive disorder: defining the phenotype. J Clin Psychiatry, 2002. 63 Suppl 6: p. 5-7. 197. Hollander, E. and J. Zohar, Beyond refractory obsessions and anxiety states: toward remission. J Clin Psychiatry, 2004. 65 Suppl 14: p. 3-5. 198. Hantouche, E.G., Trastornos obsesivocompulsivos. Encyclopédie Médico-Chirugicale, ed. E.S.e.M. Elsevier. 2001, Paris. 199. Lapanche, J. and J. Pontalis, Diccionario de Psicoanálisis. Tercera ed. 1981, Barcelona: Labor. 200. Weissman, M.M., et al., The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry, 1994. 55 Suppl: p. 5-10. 201. Heyman, I., et al., Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry, 2001. 179: p. 324-9. 202. Diniz, J.B., et al., Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. J Clin Psychiatry, 2004. 65(1): p. 22-7. 203. Douglass, H.M., et al., Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry, 1995. 34(11): p. 1424-31. 204. Eisen, J.L., et al., Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry, 2006. 47(4): p. 270-5. 205. Moritz, S., et al., Quality of life in obsessive-compulsive disorder before and after treatment. Compr Psychiatry, 2005. 46(6): p. 453-9. 206. Fontenelle, L.F., et al., Trans-cultural aspects of obsessivecompulsive disorder: a description of a Brazilian sample and a systematic review of international clinical studies. J Psychiatr Res, 2004. 38(4): p. 403-11. 207. Samuels, J.F., et al., The OCD collaborative genetics study: methods and sample description. Am J Med Genet B Neuropsychiatr Genet, 2006. 141(3): p. 201-7. 208. Arnold, P.D., et al., Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry, 2006. 63(7): p. 769-76. 209. Dickel, D.E., et al., Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry, 2006. 63(7): p. 778- 85. 210. Rosenberg, D.R. and G.L. Hanna, Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development. Biol Psychiatry, 2000. 48(12): p. 1210-22. 211. Nestadt, G., et al., A family study of obsessive-compulsive disorder. Arch Gen Psychiatry, 2000. 57(4): p. 358-63. 212. Denys, D., J. Zohar, and H.G. Westenberg, The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry, 2004. 65 Suppl 14: p. 11-7. 213. Mataix-Cols, D., M.C. Rosario-Campos, and J.F. Leckman, A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry, 2005. 162(2): p. 228-38. 214. Cullen, B., et al., Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder. Depress Anxiety, 2006. 215. Mataix-Cols, D., et al., Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry, 2004. 61(6): p. 564-76. 216. Saxena, S., et al., Cerebral glucose metabolism in obsessivecompulsive hoarding. Am J Psychiatry, 2004. 161(6): p. 1038-48. 217. Pinto, A., et al., The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry, 2006. 67(5): p. 703-11. 218. Nestadt, G., et al., The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med, 2001. 31(3): p. 481-7. 219. Overbeek, T., et al., Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry, 2002. 63(12): p. 1106-12. 220. Diniz, J.B., et al., Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder. J Psychiatr Res, 2006. 40(6): p. 487-93. 221. Samuels, J., et al., Personality dimensions and criminal arrest. Compr Psychiatry, 2004. 45(4): p. 275-80. 222. Reddy, Y.C., et al., An 11- to 13-year follow-up of 75 subjects with obsessive-compulsive disorder. J Clin Psychiatry, 2005. 66(6): p. 744-9. 223. Stewart, S.E., et al., Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand, 2004. 110(1): p. 4-13. 224. Shavitt, R.G., et al., Clinical features associated with treatment response in obsessive-compulsive disorder. Compr Psychiatry, 2006. 47(4): p. 276-81. 225. Cahill, F., Anxiety Disorders: Cognitive-Behavioral Therapy, in Kaplan & Sadock's comprehensive textbook of psychiatry / editors, Benjamin J. Sadock, Virginia A. Sadock. 2005, Lippincott Williams & Wilkins: Philadelphia, PA. 226. O'Connor, K.P., et al., Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr Scand, 2006. 113(5): p. 408-19. 227. Braga, D.T., et al., Cognitive-behavioral group therapy for obsessive-compulsive disorder: a 1-year follow-up. Acta Psychiatr Scand, 2005. 112(3): p. 180-6. 228. Fineberg, N.A., T.M. Gale, and T. Sivakumaran, A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol, 2006. 20(1): p. 97-103. 229. Tolin, D.F., et al., Cognitive-behavioral therapy for medication 30 Dra. Andrea Silvana Rosso

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015